Insulin Resistance Clinical Trial
Official title:
The Effect of Purple Sweet Potato (PSP)-Juice on Liver Enzymes and Blood Pressure
Purple Sweet Potato juice (PSP-juice) is a juice based on purple-fleshed sweet potato
concentrate, containing a high level of anthocyanins. Purple-fleshed sweet potatoes have
attracted attention to industry and scientists due to multiple physiological functions such
as radical-scavenging, ACE-inhibitory and α-glucosidase inhibitory activities in vitro, and
also hepato-protective, antihypertensive and antihyperglycemic effects in vivo. Previous
studies in Japanese subjects showed potential beneficial effects of PSP beverages on liver
function and blood pressure in volunteers with impaired hepatic function and/or
hypertension.
The main objective of this study is to examine the effect of PSP-juice on liver enzymes and
blood pressure. The secondary objective is to examine the effects of PSP-juice juice on
insulin resistance.
Status | Completed |
Enrollment | 40 |
Est. completion date | December 2009 |
Est. primary completion date | December 2009 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 40 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Healthy as assessed by the: Health and Lifestyle Questionnaire, results of the pre study laboratory tests in blood - Males/Females aged 40-70 years (boundaries included) at Day 01 of the study - Body Mass Index (BMI) 25-35 (boundaries included) kg/m2 - Liver enzymes above reference values GGT = 45 IU/L (for males) and = 35 IU/L (for females), and/or ASAT = 45 IU/L (for males and females), and/or ALAT = 50 IU/L (for males) and = 40 IU/L (for females) - Blood pressure (automated measurements at site): systolic blood pressure 130-159 mm Hg (boundaries included) and/or diastolic blood pressure 85-99 mm Hg (boundaries included) - Voluntary participation - Having given written informed consent - Willing to comply with the study procedures - Willing to give up blood/plasma donation during the study - Willing to accept use of all nameless data, including publication, and the confidential use and storage of all data for at least 15 years - Willing to accept the disclosure of the financial benefit of participation in the study to the authorities concerned. Exclusion Criteria: - Participation in any clinical trial including blood sampling and/or administration of substances up to 90 days before Day 01 of this study - Participation in any non-invasive clinical trial up to 30 days before Day 01 of this study, including no blood sampling and/or oral, intravenous, inhalatory administration of substances - Having a history of medical or surgical events that may significantly affect the study outcome - Any concomitant medication, with the exception of occasional use of a paracetamol tablet, that may influence the outcome of the study (to be judged by the medical investigator) - Food allergy/intolerance - Alcohol consumption > 28 units/week for males and > 21 units/week for females - Smoking > 10 cigarettes per day - Reported unexplained weight loss or gain of > 2 kg in the month prior to the pre study screening - Reported slimming or medically prescribed diet - Participation in night shift work - Pregnant or lactating or wishing to become pregnant in the period of the study - Personnel of TNO Quality of Life, their partner and their first and second degree relatives - Not having a general practitioner - Not willing to accept information-transfer concerning participation in the study, or information regarding his/her health, like laboratory results, findings at anamnesis or physical examination and eventual adverse events to and from his general practitioner. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Netherlands | TNO Quality of Life | Zeist | Utrecht |
Lead Sponsor | Collaborator |
---|---|
TNO | Yakult Honsha Co., LTD |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | liver enzymes | every 2 weeks during 8-weeks intervention | No | |
Secondary | blood pressure | every 2 weeks during 8-weeks intervention | No | |
Secondary | insulin resistance | every 2 weeks during 8-weeks intervention | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03142633 -
MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
|
||
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Recruiting |
NCT05354245 -
Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL)
|
N/A | |
Completed |
NCT03383822 -
Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Suspended |
NCT03652987 -
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
|
||
Completed |
NCT04203238 -
Potato Research for Enhancing Metabolic Outcomes
|
N/A | |
Recruiting |
NCT03658564 -
Preoperative Oral Carbohydrate Treatment Minimizes Insulin Resistance
|
N/A | |
Completed |
NCT04183257 -
Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
|
Phase 4 | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT03627104 -
Effect of Dietary Protein and Energy Restriction in the Improvement of Insulin Resistance in Subjects With Obesity
|
N/A | |
Completed |
NCT05124847 -
TREating Pediatric Obesity
|
N/A | |
Active, not recruiting |
NCT03288025 -
Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE)
|
N/A | |
Completed |
NCT03809182 -
Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.
|
Phase 4 | |
Completed |
NCT01809288 -
Identifying Risk for Diabetes and Heart Disease in Women
|
||
Completed |
NCT04642482 -
Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity
|
Phase 4 | |
Terminated |
NCT03278236 -
Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men?
|
N/A | |
Not yet recruiting |
NCT06159543 -
The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes
|
N/A | |
Not yet recruiting |
NCT05540249 -
Pre-operative Carbohydrates in Diabetic Patients Undergoing CABG
|
N/A | |
Withdrawn |
NCT04741204 -
Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer
|
Phase 4 |